November 21, 2025

Delcath Systems, Inc. (DCTH) Stock Analysis: A 172% Potential Upside in the Healthcare Sector

Delcath Systems, Inc. (NASDAQ: DCTH) emerges as a compelling option in the healthcare sector, particularly for investors eyeing the medical devices industry. With a market capitalization..

Praxis Precision Medicines, Inc (PRAX) Stock Analysis: A 97% Potential Upside Amidst Biotech Ventures

Praxis Precision Medicines, Inc (NASDAQ: PRAX), a promising player in the biotechnology sector, is making waves with its innovative approach to treating central nervous system (CNS)..

Avadel Pharmaceuticals (AVDL) Stock Analysis: Navigating a Complex Landscape with Strong Revenue Growth

Avadel Pharmaceuticals plc (NASDAQ: AVDL) presents a unique opportunity for investors interested in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. Headquartered..

LENZ Therapeutics, Inc. (LENZ) Stock Analysis: Unveiling a 93% Upside Potential in Biotech

Investors in the biotechnology sector are always on the lookout for the next breakthrough, and LENZ Therapeutics, Inc. (NASDAQ: LENZ) might just be that opportunity. With..

Bicara Therapeutics Inc. (BCAX) Investor Outlook: Analyzing the 101% Potential Upside

Bicara Therapeutics Inc. (NASDAQ: BCAX) is catching the attention of investors with its remarkable potential upside of 101.31%. As a clinical-stage biopharmaceutical company headquartered in Boston,..

Syndax Pharmaceuticals, Inc. (SNDX) Stock Analysis: A Promising 124% Upside on the Horizon

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) stands out in the biotechnology industry not only for its innovative cancer therapies but also for its compelling growth potential. With..

Ardelyx, Inc. (ARDX) Stock Analysis: Unveiling a 107% Potential Upside with Strong Buy Ratings

Ardelyx, Inc. (NASDAQ: ARDX), a biotechnology company specializing in innovative treatments for unmet medical needs, stands out in the healthcare sector with a current market capitalization..

Keros Therapeutics, Inc. (KROS) Investor Outlook: Unveiling a 38% Potential Upside in Biotech

Keros Therapeutics, Inc. (NASDAQ: KROS), a clinical-stage biopharmaceutical innovator, has captured investor attention with its ambitious pipeline and an intriguing 38.23% potential upside based on analyst..

AnaptysBio, Inc. (ANAB): Exploring a Potential 69.94% Upside in the Biotech Sector

As the biotechnology sector continues to capture investor interest, AnaptysBio, Inc. (NASDAQ: ANAB) emerges as a compelling player with a significant potential upside. Specializing in immunology..

Avanos Medical, Inc. (AVNS) Stock Analysis: Navigating Challenges in the Medical Device Sector

Avanos Medical, Inc. (NYSE: AVNS), a prominent player in the healthcare sector, focuses on delivering innovative medical device solutions across the globe. While its market presence..

AbCellera Biologics Inc. (ABCL) Stock Analysis: Exploring a 193% Potential Upside in the Biotech Sphere

AbCellera Biologics Inc. (NASDAQ: ABCL) is capturing the attention of individual investors with its compelling growth prospects in the dynamic biotechnology industry. Headquartered in Vancouver, Canada,..

Cronos Group Inc. (CRON) Stock Analysis: Assessing the Potential of This Cannabis Player Amidst Market Challenges

For investors keeping a close eye on the volatile cannabis sector, Cronos Group Inc. (NASDAQ: CRON) offers a compelling case study. With its roots firmly planted..

Embecta Corp. (EMBC) Stock Analysis: Seizing a 21% Potential Upside in Healthcare

Embecta Corp. (NASDAQ: EMBC), a key player in the healthcare sector, presents an intriguing opportunity for investors looking to tap into the medical instruments and supplies..

Simulations Plus, Inc. (SLP) Stock Analysis: Unveiling a 37.89% Potential Upside for Investors

Simulations Plus, Inc. (NASDAQ: SLP), a key player in the Health Information Services industry, presents an intriguing investment opportunity with a notable 37.89% potential upside, according..

RxSight, Inc. (RXST) Stock Analysis: Navigating Challenges with Innovative Medical Device Solutions

RxSight, Inc. (NASDAQ: RXST) presents an intriguing opportunity within the healthcare sector, specifically in the medical devices industry. Specializing in innovative solutions for cataract surgery, RxSight..

Replimune Group, Inc. (REPL) Stock Analysis: A 39.53% Upside Potential in Cancer Immunotherapy

Replimune Group, Inc. (NASDAQ: REPL) presents a compelling opportunity for investors with its focus on pioneering oncolytic immunotherapies aimed at revolutionizing cancer treatment. As a clinical-stage..

Evolus, Inc. (EOLS) Stock Analysis: Unveiling a Potential 182% Upside in the Healthcare Sector

Evolus, Inc. (EOLS), a key player in the healthcare sector specializing in aesthetic products, is capturing investor attention with its significant potential upside of nearly 182%...

Savara, Inc. (SVRA) Stock Analysis: Exploring a Potential 120% Upside in the Biotech Sector

Savara, Inc. (NASDAQ: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases, has been attracting investor attention with its promising potential for significant upside. Currently..

iRadimed Corporation (IRMD) Stock Analysis: Strong Growth in the Medical Device Sector with a 13% Upside Potential

iRadimed Corporation (IRMD), a key player in the medical device sector, stands out with its innovative MRI-compatible equipment and promising financial outlook. Headquartered in Winter Springs,..

Geron Corporation (GERN) Stock Analysis: Potential 203% Upside Amid Biotech Breakthroughs

Geron Corporation (NASDAQ: GERN), a biopharmaceutical entity embedded in the biotechnology sector, has garnered investor attention due to its promising oncology therapeutic developments and significant potential..

Search

Funds

November 21, 2025

Search

Funds

November 21, 2025

FTSE 100

Funds